Page last updated: 2024-11-03

practolol and Scleroderma, Systemic

practolol has been researched along with Scleroderma, Systemic in 2 studies

Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Graham, JR1
McQueen, A1
Behan, WM1

Other Studies

2 other studies available for practolol and Scleroderma, Systemic

ArticleYear
Drug-induced localized systemic scleroses.
    Transactions of the American Clinical and Climatological Association, 1981, Volume: 92

    Topics: Adrenergic beta-Antagonists; Humans; Methysergide; Metoprolol; Practolol; Propranolol; Scleroderma,

1981
Immunofluorescence microscopy. The "string of Pearls" phenomenon-an immunofluorescent serological finding in patients screened for adverse drug reactions.
    The American Journal of dermatopathology, 1982, Volume: 4, Issue:2

    Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; Dermatomyositis; Drug Eruptions; Epidermis; Esophagu

1982